Meraviglia P - Search Results

1

One-year durability of anti-spike IgG to SARS-CoV-2: Preliminary data from the anticrown prospective observational study one year durability of COVID-19 anti-spike IgG.

Capetti AF, Borgonovo F, Mileto D, Gagliardi G, Mariani C, Lupo A, Dedivitiis G, Meraviglia P, Pellicciotta M, Armiento L, Cossu MV, Rizzardini G. Capetti AF, et al. Among authors: meraviglia p. J Infect. 2021 Aug;83(2):237-279. doi: 10.1016/j.jinf.2021.05.023. Epub 2021 May 27. J Infect. 2021. PMID: 34052240 Free PMC article.

2

Virological success of lopinavir/ritonavir salvage regimen is affected by an increasing number of lopinavir/ritonavir-related mutations.

Bongiovanni M, Bini T, Adorni F, Meraviglia P, Capetti A, Tordato F, Cicconi P, Chiesa E, Cordier L, Cargnel A, Landonio S, Rusconi S, d'Arminio Monforte A. Bongiovanni M, et al. Among authors: meraviglia p. Antivir Ther. 2003 Jun;8(3):209-14. Antivir Ther. 2003. PMID: 12924537 Clinical Trial.

3

Use of lopinavir/ritonavir in HIV-infected patients failing a first-line protease-inhibitor-containing HAART.

Bongiovanni M, Chiesa E, Di Biagio A, Meraviglia P, Capetti A, Tordato F, Cicconi P, Biasi P, Bini T, d'Arminio Monforte A. Bongiovanni M, et al. Among authors: meraviglia p. J Antimicrob Chemother. 2005 Jun;55(6):1003-7. doi: 10.1093/jac/dki113. Epub 2005 Apr 11. J Antimicrob Chemother. 2005. PMID: 15824089

4

Lopinavir/ritonavir pharmacokinetics in HIV/HCV-coinfected patients with or without cirrhosis.

Micheli V, Regazzi M, Dickinson L, Meraviglia P, Villani P, Khoo SH, Viganò P, Cordier L, Cusato M, Duca P, Orlando G, Rizzardini G, Back DJ, Cargnel A. Micheli V, et al. Among authors: meraviglia p. Ther Drug Monit. 2008 Jun;30(3):306-13. doi: 10.1097/FTD.0b013e318177209e. Ther Drug Monit. 2008. PMID: 18520602 Free PMC article. Clinical Trial.

5

Immune activation, apoptosis, and Treg activity are associated with persistently reduced CD4+ T-cell counts during antiretroviral therapy.

Piconi S, Trabattoni D, Gori A, Parisotto S, Magni C, Meraviglia P, Bandera A, Capetti A, Rizzardini G, Clerici M. Piconi S, et al. Among authors: meraviglia p. AIDS. 2010 Aug 24;24(13):1991-2000. doi: 10.1097/QAD.0b013e32833c93ce. AIDS. 2010. PMID: 20651586

6

Prevalence and factors associated with idiopathic hypercalciuria in HIV patients on combination antiretroviral therapy.

Pocaterra D, Carenzi L, Ricci E, Minisci D, Schiavini M, Gervasoni C, Meraviglia P, Bevilacqua M, Rizzardini G, Bonfanti P. Pocaterra D, et al. Among authors: meraviglia p. Int J STD AIDS. 2010 Dec;21(12):829-31. doi: 10.1258/ijsa.2010.010111. Int J STD AIDS. 2010. PMID: 21297093

7

Eligibility and feasibility of the treatment of chronic hepatitis C in a Cohort of Italian HIV-positive patients at a single HIV reference center.

Angeli E, Mainini A, Meraviglia P, Schiavini M, Ricci E, Giorgi R, Gubertini G, Rizzardini G. Angeli E, et al. Among authors: meraviglia p. AIDS Patient Care STDS. 2011 May;25(5):295-301. doi: 10.1089/apc.2010.0342. Epub 2011 Apr 2. AIDS Patient Care STDS. 2011. PMID: 21457054

8

Hydroxychloroquine drastically reduces immune activation in HIV-infected, antiretroviral therapy-treated immunologic nonresponders.

Piconi S, Parisotto S, Rizzardini G, Passerini S, Terzi R, Argenteri B, Meraviglia P, Capetti A, Biasin M, Trabattoni D, Clerici M. Piconi S, et al. Among authors: meraviglia p. Blood. 2011 Sep 22;118(12):3263-72. doi: 10.1182/blood-2011-01-329060. Epub 2011 May 16. Blood. 2011. PMID: 21576701 Free article.

9

Secondary hyperparathyroidism in HIV patients: is there any responsibility of highly active antiretroviral therapy?

Pocaterra D, Carenzi L, Ricci E, Minisci D, Schiavini M, Meraviglia P, Bevilacqua M, Zucchi P, Bonfanti P, Rizzardini G. Pocaterra D, et al. Among authors: meraviglia p. AIDS. 2011 Jul 17;25(11):1430-3. doi: 10.1097/QAD.0b013e328349060e. AIDS. 2011. PMID: 21617518

10

Expression of interleukin-15 and interleukin-15Rα in monocytes of HIV type 1-infected patients with different courses of disease progression.

Tarkowski M, Ferraris L, Martone S, Strambio de Castillia F, Misciagna D, Mazzucchelli RI, Lattuada E, Paraninfo G, Galli M, Riva A; Elvis Study Group. Tarkowski M, et al. AIDS Res Hum Retroviruses. 2012 Jul;28(7):693-701. doi: 10.1089/AID.2010.0317. Epub 2011 Sep 23. AIDS Res Hum Retroviruses. 2012. PMID: 21902580 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

96 results

Search Page